Alnylam Pharmaceuticals | ALNY - Capital Y Las Reservas

Precio De Mercado
301.30
Cambio Diario
-0.81 -0.27%
Mensual
-4.68%
Anual
14.46%
Q2 Expectativa
299.00




Capital Y Las Reservas Cambio Fecha
Acadia Pharmaceuticals USD 917.27M 94.89M 2025-09
Agios Pharmaceuticals USD 1.11B 84M 2026-03
Alnylam Pharmaceuticals USD 789.18M 555.28M 2025-12
Amgen USD 8.66B 961M 2025-12
Arrowhead Research USD 568.42M 102.37M 2025-12
BioCryst Pharmaceuticals USD -119.15M 268.74M 2025-12
BioMarin Pharmaceutical USD 6.09B 30.29M 2025-12
Incyte USD 5.62B 455.37M 2026-03
Ionis Pharmaceuticals USD 491.41M 2.32M 2026-03
Moderna USD 8.65B 680M 2025-12
Neurocrine Biosciences USD 3.25B 249.5M 2025-12
Novartis USD 46.13B 1.8B 2025-12
PTC Therapeutics USD -205.31M 49.56M 2025-12
Regeneron Pharmaceuticals USD 31.42B 166.7M 2026-03
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Sanofi EUR 71.71B 14.25B 2025-12
Sarepta Therapeutics USD 1.14B 179.5M 2025-12
Takeda JPY 7.64T 513.39B 2025-12
Tectonic Therapeutic USD 251.33M 16.2M 2025-12
Ultragenyx Pharmaceutical USD 9.16M 142.13M 2025-09
Vertex Pharmaceuticals USD 18.67B 1.35B 2025-12
Xencor USD 635.59M 10.27M 2025-12